Maze Therapeutics, Inc. Common Stock (MAZE) — Free Cash Flow Generation Index
Maze Therapeutics, Inc. Common Stock (MAZE) has a Free Cash Flow Generation Index of 1.00x as of June 2024. Free cash flow of $144.89 Million represents 1% of operating cash flow ($145.05 Million). Explore how much does Maze Therapeutics, Inc. Common Stock reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Maze Therapeutics, Inc. Common Stock Free Cash Flow Generation Index (2024–2024)
Historical FCF Generation Index trend for Maze Therapeutics, Inc. Common Stock across 1 annual periods. For the full cash flow conversion analysis, see Maze Therapeutics, Inc. Common Stock (MAZE) cash flow conversion.
Annual Free Cash Flow Generation for Maze Therapeutics, Inc. Common Stock (2024–2024)
Year-by-year Free Cash Flow Generation Index for Maze Therapeutics, Inc. Common Stock. Check how aggressively does Maze Therapeutics, Inc. Common Stock reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.98x | $74.81 Million | $75.95 Million | $1.15 Million | — |